JPS50116623A - - Google Patents

Info

Publication number
JPS50116623A
JPS50116623A JP50007408A JP740875A JPS50116623A JP S50116623 A JPS50116623 A JP S50116623A JP 50007408 A JP50007408 A JP 50007408A JP 740875 A JP740875 A JP 740875A JP S50116623 A JPS50116623 A JP S50116623A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50007408A
Other languages
Japanese (ja)
Other versions
JPS5837284B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50116623A publication Critical patent/JPS50116623A/ja
Publication of JPS5837284B2 publication Critical patent/JPS5837284B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP50007408A 1974-01-18 1975-01-16 セイヤクソセイブツノセイホウ Expired JPS5837284B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JPS50116623A true JPS50116623A (zh) 1975-09-12
JPS5837284B2 JPS5837284B2 (ja) 1983-08-15

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50007408A Expired JPS5837284B2 (ja) 1974-01-18 1975-01-16 セイヤクソセイブツノセイホウ

Country Status (18)

Country Link
JP (1) JPS5837284B2 (zh)
AT (1) AT349150B (zh)
AU (1) AU485660B2 (zh)
BE (1) BE824509A (zh)
CA (1) CA1040532A (zh)
CH (1) CH622947A5 (zh)
DE (1) DE2501787A1 (zh)
DK (1) DK151770C (zh)
ES (1) ES433908A1 (zh)
FI (1) FI750113A (zh)
FR (1) FR2258177B1 (zh)
GB (1) GB1478742A (zh)
IE (1) IE40361B1 (zh)
IT (1) IT1036072B (zh)
LU (1) LU71668A1 (zh)
NL (1) NL185130C (zh)
SE (1) SE437930B (zh)
ZA (1) ZA74385B (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6248624A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療用医薬組成物
JPS6248623A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療のための医薬組成物
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
JPH02145523A (ja) * 1988-10-08 1990-06-05 Dr R Pfleger Chem Fab Gmbh 液状のビスマス含有医薬品、その製造方法およびその使用

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
IE65964B1 (en) * 1990-07-20 1996-01-24 Slagel David Products and processes for the treatment of the alimentary canal
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
JPS6248624A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療用医薬組成物
JPS6248623A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療のための医薬組成物
JPH02145523A (ja) * 1988-10-08 1990-06-05 Dr R Pfleger Chem Fab Gmbh 液状のビスマス含有医薬品、その製造方法およびその使用

Also Published As

Publication number Publication date
SE7500501L (zh) 1975-07-21
DK12675A (zh) 1975-09-15
AU7729375A (en) 1976-07-15
JPS5837284B2 (ja) 1983-08-15
FR2258177B1 (zh) 1978-07-21
ES433908A1 (es) 1976-11-16
SE437930B (sv) 1985-03-25
CA1040532A (en) 1978-10-17
DK151770B (da) 1988-01-04
AU485660B2 (en) 1977-07-28
ZA74385B (en) 1975-08-27
IT1036072B (it) 1979-10-30
FI750113A (zh) 1975-07-19
DE2501787C2 (zh) 1987-11-12
GB1478742A (en) 1977-07-06
NL7500552A (nl) 1975-07-22
CH622947A5 (en) 1981-05-15
ATA31875A (de) 1978-08-15
IE40361B1 (en) 1979-05-09
LU71668A1 (zh) 1975-06-24
FR2258177A1 (zh) 1975-08-18
IE40361L (en) 1975-07-18
DE2501787A1 (de) 1975-07-24
DK151770C (da) 1989-11-06
NL185130C (nl) 1990-02-01
AT349150B (de) 1979-03-26
NL185130B (nl) 1989-09-01
BE824509A (fr) 1975-07-17

Similar Documents

Publication Publication Date Title
FR2258177B1 (zh)
FR2257986A1 (zh)
AU480152B2 (zh)
FR2289113B1 (zh)
AU495841B2 (zh)
FR2287174B1 (zh)
FR2273257B1 (zh)
FR2262851A1 (zh)
FR2282463B1 (zh)
FR2290628B3 (zh)
FR2290355B1 (zh)
AR199810A1 (zh)
AU8191875A (zh)
JPS50101332U (zh)
BG20001A1 (zh)
BG20430A1 (zh)
BE829575A (zh)
BE830029A (zh)
BG20237A1 (zh)
BG19710A1 (zh)
BE827113A (zh)
BG19722A1 (zh)
BG20501A1 (zh)
BG19729A1 (zh)
BG19867A1 (zh)